Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 1.24M
2: EX-10.U Material Contract HTML 59K
3: EX-21 Subsidiaries List HTML 29K
4: EX-23 Consent of Expert or Counsel HTML 32K
5: EX-24 Power of Attorney HTML 77K
6: EX-31.A Certification -- §302 - SOA'02 HTML 34K
7: EX-31.B Certification -- §302 - SOA'02 HTML 34K
8: EX-32.A Certification -- §906 - SOA'02 HTML 31K
9: EX-32.B Certification -- §906 - SOA'02 HTML 31K
15: R1 Cover Page HTML 94K
16: R2 Audit Information HTML 35K
17: R3 Consolidated Statements of Operations HTML 119K
18: R4 Consolidated Statements of Comprehensive Income HTML 50K
19: R5 Consolidated Statements of Financial Position HTML 134K
20: R6 Consolidated Statements of Financial Position HTML 48K
(Parenthetical)
21: R7 Consolidated Statements of Cash Flows HTML 127K
22: R8 Consolidated Statements of Shareholders' HTML 76K
Investment
23: R9 Consolidated Statements of Shareholders' HTML 32K
Investment (Parenthetical)
24: R10 Summary of Accounting Policies HTML 36K
25: R11 Coronavirus (Covid-19) HTML 33K
26: R12 Dermstore Sale HTML 32K
27: R13 Revenues HTML 67K
28: R14 Cost of Sales and Selling, General and HTML 37K
Administrative Expenses
29: R15 Consideration Received from Vendors HTML 33K
30: R16 Advertising Costs HTML 32K
31: R17 Fair Value Measurements HTML 55K
32: R18 Cash and Cash Equivalents HTML 41K
33: R19 Inventory HTML 33K
34: R20 Other Current Assets HTML 38K
35: R21 Property and Equipment HTML 37K
36: R22 Other Noncurrent Assets HTML 39K
37: R23 Accrued and Other Current Liabilities HTML 44K
38: R24 Commitments and Contingencies HTML 37K
39: R25 Commercial Paper and Long-Term Debt HTML 58K
40: R26 Derivative Financial Instruments HTML 46K
41: R27 Leases HTML 156K
42: R28 Income Taxes HTML 92K
43: R29 Other Noncurrent Liabilities HTML 41K
44: R30 Share Repurchase HTML 38K
45: R31 Share-Based Compensation HTML 72K
46: R32 Defined Contribution Plans HTML 44K
47: R33 Pension Plans HTML 152K
48: R34 Accumulated Other Comprehensive Loss HTML 48K
49: R35 Summary of Accounting Policies (Policies) HTML 103K
50: R36 Revenues (Tables) HTML 62K
51: R37 Fair Value Measurements (Tables) HTML 58K
52: R38 Cash and Cash Equivalents (Tables) HTML 39K
53: R39 Other Current Assets (Tables) HTML 38K
54: R40 Property and Equipment (Tables) HTML 34K
55: R41 Other Noncurrent Assets (Tables) HTML 39K
56: R42 Accrued and Other Current Liabilities (Tables) HTML 44K
57: R43 Commercial Paper and Long-Term Debt (Tables) HTML 56K
58: R44 Derivative Financial Instruments (Tables) HTML 44K
59: R45 Leases (Tables) HTML 112K
60: R46 Income Taxes (Tables) HTML 94K
61: R47 Other Noncurrent Liabilities (Tables) HTML 41K
62: R48 Share Repurchase (Tables) HTML 39K
63: R49 Share-Based Compensation (Tables) HTML 71K
64: R50 Defined Contribution Plans (Tables) HTML 42K
65: R51 Pension Plans (Tables) HTML 159K
66: R52 Accumulated Other Comprehensive Loss (Tables) HTML 47K
67: R53 Coronavirus (Covid-19) (Details) HTML 34K
68: R54 Dermstore Sale (Details) HTML 40K
69: R55 Revenues - Disaggregation of Revenue (Details) HTML 57K
70: R56 Revenues - Narrative (Details) HTML 46K
71: R57 Revenues - Gift Card Liability Activity (Details) HTML 36K
72: R58 Advertising Costs (Details) HTML 32K
73: R59 Fair Value Measurements - Schedule of Fair Value HTML 48K
Measurements - Recurring Basis (Details)
74: R60 Fair Value Measurements - Schedule of Significant HTML 37K
Financial Instruments Not Measured at Fair Value
(Details)
75: R61 Cash and Cash Equivalents - Narrative (Details) HTML 38K
76: R62 Cash and Cash Equivalents - Schedule of Cash and HTML 41K
Cash Equivalents (Details)
77: R63 Other Current Assets (Details) HTML 40K
78: R64 Property and Equipment - Narrative (Details) HTML 35K
79: R65 Property and Equipment - Useful Lives (Details) HTML 42K
80: R66 Other Noncurrent Assets (Details) HTML 44K
81: R67 Accrued and Other Current Liabilities (Details) HTML 51K
82: R68 Commitments and Contingencies (Details) HTML 46K
83: R69 Commercial Paper and Long-Term Debt - Schedule of HTML 59K
Carrying Value and Maturities of Debt Portfolio
(Details)
84: R70 Commercial Paper and Long-Term Debt - Schedule of HTML 44K
Required Principal Payments (Details)
85: R71 Commercial Paper and Long-Term Debt - Narrative HTML 85K
(Details)
86: R72 Derivative Financial Instruments - Narrative HTML 44K
(Details)
87: R73 Derivative Financial Instruments - Effect of HTML 35K
Hedges On Debt (Details)
88: R74 Derivative Financial Instruments - Effect of HTML 37K
Hedges on Net Interest Expense (Details)
89: R75 Leases - Narrative (Details) HTML 37K
90: R76 Leases - Lease Assets and Liabilities (Details) HTML 60K
91: R77 Leases - Lease Cost (Details) HTML 46K
92: R78 Leases - Maturity of Lease Liabilities (Details) HTML 91K
93: R79 Leases - Lease Term and Discount Rate (Details) HTML 41K
94: R80 Leases - Other Information (Details) HTML 37K
95: R81 Income Taxes - Narrative (Details) HTML 47K
96: R82 Income Taxes - Schedule of Tax Rate Reconciliation HTML 48K
- Continuing Operations (Details)
97: R83 Income Taxes - Schedule of Provision for Income HTML 58K
Taxes (Details)
98: R84 Income Taxes - Schedule of Net Deferred Tax HTML 64K
Asset/(Liability) (Details)
99: R85 Income Taxes - Schedule of Reconciliation of HTML 42K
Liability for Unrecognized Tax Benefits (Details)
100: R86 Other Noncurrent Liabilities (Details) HTML 47K
101: R87 Share Repurchase (Details) HTML 37K
102: R88 Share-Based Compensation - Narrative (Details) HTML 73K
103: R89 Share-Based Compensation - Schedule of Restricted HTML 65K
Stock Activity and Performance Share Unit Activity
(Details)
104: R90 Share-Based Compensation - Schedule of Stock HTML 63K
Option Activity (Details)
105: R91 Share-Based Compensation - Schedule of Stock HTML 37K
Option Exercises (Details)
106: R92 Defined Contribution Plans - Narrative (Details) HTML 42K
107: R93 Defined Contribution Plans - Schedule of Plan HTML 40K
Expenses (Details)
108: R94 Pension Plans - Schedule of Recognition of HTML 44K
Funded/(Underfunded) Status (Details)
109: R95 Pension Plans - Schedule of Estimated Future HTML 42K
Benefit Payments (Details)
110: R96 Pension Plans - Schedule of Net Pension Benefit HTML 52K
Expense (Details)
111: R97 Pension Plans - Schedule of Benefit Obligation HTML 37K
Weighted Average Assumptions (Details)
112: R98 Pension Plans - Schedule of Net Periodic Benefit HTML 40K
Expense Weighted Average Assumptions (Details)
113: R99 Pension Plans - Narrative (Details) HTML 60K
114: R100 Pension Plans - Schedule of Change in Projected HTML 54K
Benefit Obligation (Details)
115: R101 Pension Plans - Schedule of Change in Plan Assets HTML 52K
(Details)
116: R102 Pension Plans - Schedule of Asset Category HTML 52K
(Details)
117: R103 Pension Plans - Schedule of Fair Value HTML 60K
Measurements (Details)
118: R104 Pension Plans - Schedule of Amounts in Accumulated HTML 41K
Other Comprehensive Income (Details)
119: R105 Accumulated Other Comprehensive Loss (Details) HTML 63K
122: XML IDEA XML File -- Filing Summary XML 226K
120: XML XBRL Instance -- tgt-20220129_htm XML 2.44M
121: EXCEL IDEA Workbook of Financial Reports XLSX 128K
11: EX-101.CAL XBRL Calculations -- tgt-20220129_cal XML 296K
12: EX-101.DEF XBRL Definitions -- tgt-20220129_def XML 562K
13: EX-101.LAB XBRL Labels -- tgt-20220129_lab XML 2.19M
14: EX-101.PRE XBRL Presentations -- tgt-20220129_pre XML 1.21M
10: EX-101.SCH XBRL Schema -- tgt-20220129 XSD 233K
123: JSON XBRL Instance as JSON Data -- MetaLinks 531± 768K
124: ZIP XBRL Zipped Folder -- 0000027419-22-000007-xbrl Zip 713K
1.I have reviewed this Annual Report on Form 10-K of Target Corporation;
2.Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.disclosed in this report any change in the registrant’s
internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and
the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
